Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy purple patches on his pores and skin. Then got here the ache and swelling within the joints of his palms, making it tough to do his work at a financial institution.
His major care physician referred him to a rheumatologist, who identified psoriatic arthritis. She suggested Mishra that whereas there’s no treatment, there have been many new medicines that might maintain the autoimmune illness in examine, and he or she beneficial one, Otezla.
At first, Mishra balked. He knew the medicines had been costly. He frightened about unintended effects. He thought he might handle with over-the-counter medicine.
However by September he was in a lot ache that he agreed to strive a starter pack supplied by Otezla’s producer, Amgen. It labored: The pores and skin lesions disappeared, and the joint ache that saved him up at night time dissipated. He was bought.
His rheumatologist bought approval for the drug from his insurer, UnitedHealthcare, and signed him up for Amgen’s copayment help program. Having enrolled different sufferers, she instructed Mishra the copay card, much like a bank card, ought to final a 12 months, he mentioned, shielding him from the drug’s excessive record worth: round $5,000 for a 30-day provide, based on GoodRx.
He mentioned the physician defined that, in her sufferers’ expertise, insurers and their pharmacy profit managers negotiated a deeply discounted worth with Amgen — she estimated $1,400 to $2,200 a month. Sufferers paid a proportion of that quantity, their “affected person accountability,” utilizing the copay card.
Mishra mentioned he was authorised for a copay card protecting $9,450 a 12 months. “I used to be blissful after I bought the message,” he mentioned.
He added that the physician reassured him about the price. “She mentioned: ‘You shouldn’t must pay something out-of-pocket. Your copay card will cowl this.’”
He began the medication and, at first, paid nothing.
Then the invoice got here.
The Medical Service
Otezla, which is available in a tablet, is authorised to deal with some autoimmune issues, together with psoriatic arthritis.
The Invoice
$441.02, for the second month’s fill of the drug — earlier than Mishra selected to ration moderately than refill his prescription, as a result of his copay card was empty.
The insurance coverage assertion from UnitedHealthcare’s pharmacy profit supervisor, Optum Rx — one other subsidiary of the identical mum or dad firm, UnitedHealth Group — confirmed it didn’t present a negotiated low cost and lined simply $308.34 of the total $5,253.85 cost for a 30-day provide. The fees for the second month depleted the copay card and left Mishra owing the steadiness.
The Billing Downside: Copay Card ‘Tug-of-Battle’
Copay help packages are a part of a “tug-of-war between drug producers and insurers,” mentioned Aaron Kesselheim, a professor of medication at Harvard Medical Faculty who research the pharmaceutical business.
The worth of drugmakers’ copay playing cards has develop into extra unpredictable as insurers attempt to limit their use. Many insurance coverage, as an example, don’t depend the cash from a copay program towards a affected person’s deductible.
And sufferers who use a copay card can wind up paying full or practically full worth moderately than the discounted price negotiated by their insurer’s pharmacy profit supervisor.
“While you bought your medicine a Producer Coupon was used,” Mishra’s rationalization of advantages statements learn, in tiny letters. The quantity the copay card lined “was not utilized in the direction of your Deductible and Out of Pocket Most.”
Caroline Landree, a spokesperson for UnitedHealthcare, mentioned that “the copay card is an association between the affected person and the pharmacy. It’s used outdoors of insurance coverage.”
In an emailed assertion, Elissa Snook, a spokesperson for Amgen, expressed a distinct view of who was answerable for Mishra’s dilemma: “Copay help packages are designed to assist sufferers begin and keep on prescribed remedy, however the worth of that help will be exhausted extra shortly when a well being plan requires sufferers to pay the total record worth of a drugs.”
Few sufferers can afford the record costs that pharmaceutical producers cost in america for brand-name medicine.
Insurers insulate themselves and their prospects from these greater costs via pharmacy profit managers’ negotiated reductions. They may, for instance, designate sure medicine as most well-liked medicines for plan members in change for the producer agreeing to a major worth discount.
Producers’ copay help packages provide one other manner for sufferers to keep away from paying full worth. The help is meant to encourage sufferers to decide on an costly, brand-name drug — not one which “treats the identical situation that the insurer has gotten for a less expensive worth,” mentioned Fiona Scott Morton, an economist on the Yale Faculty of Administration who research drug pricing.
The help additionally discourages sufferers from discussing with their physician whether or not a less expensive, generic drug would do, drug business researchers mentioned.
Whereas the Meals and Drug Administration first authorised a generic model of Otezla in 2021, Amgen has sued to dam U.S. gross sales of its generic rivals, making certain the brand-name drug has patent safety till 2028. Generic variations can be found abroad and in Canada, the place sufferers can buy it in some instances for lower than $100 a month.
Mishra mentioned one in every of his kids joked he might cowl a visit to go to family members in India just by buying his drugs whereas he was there.
The Decision
Mishra has a well being plan with a $5,000 deductible and contributes to a tax-free well being financial savings account.
In September, he paid for the primary month’s provide of Otezla with the copay card. However paying for October’s provide emptied the cardboard — which he initially anticipated to final a 12 months — and he mentioned he used his HSA to pay for the roughly $400 that remained.
However cautious of what the drug would price in November and December, Mishra mentioned, he tried to unfold out the drugs he had left from the starter pack and the primary two months’ provide. He skipped some days and took solely half of the prescribed dose to stretch the provision for 2 extra months, realizing he would get a brand new copay card with the brand new 12 months. Lots of his signs returned, he mentioned.
In January, he bought one other copay card, good for $9,450, which once more wasn’t ample to pay for 2 months’ provide. He once more paid the remaining steadiness in February from his HSA to depend towards his $5,000 annual deductible. This time he owed $550, he mentioned.
Mishra mentioned his signs have resolved. With no clue what he’d be charged for March’s provide, he known as UnitedHealthcare in late February and was instructed he would want to pay $4,450 for the month to satisfy his out-of-pocket most, he mentioned.
However he mentioned he pressed the consultant additional, asking why UnitedHealthcare doesn’t have a negotiated worth. It does, they instructed him. “Precise worth is $6,995.36.”
The Takeaway
Copay playing cards and drugmaker packages that promise sufferers “you could possibly pay $0” work in mysterious methods.
On the one hand, they encourage sufferers to make use of brand-name or costly medicine which are off insurers’ formularies, or lists of most well-liked, lined medicine. On the opposite, many sufferers couldn’t afford prescribed medicines with out them.
Sufferers with public insurance coverage, equivalent to Medicare and Medicaid, aren’t permitted to make use of the playing cards, as a result of the federal government considers them an finish run round its makes an attempt to convey down drug spending.
Utilizing a copay card has gotten trickier as insurers push again. First, sufferers want to grasp whether or not there may be an annual greenback or time restrict on the cardboard and the way it works with their insurance coverage. In any other case, they danger ending up reliant on a drug they’ll’t afford.
Cheaper medicine typically can suffice. For instance, there are a variety of medicines to deal with psoriatic arthritis, a few of which can be cheaper or have higher protection from a selected insurer. Sufferers ought to ask their medical doctors whether or not cheaper medicines will work.
It additionally may also help sufferers to think about their prescriptions once they choose a well being plan. Landree, of UnitedHealthcare, mentioned Mishra might have chosen a plan for 2026 that may have lined Otezla for a $100 copay every month, although that may have meant the next premium.
“Personally I’m not in monetary misery — I can afford it,” Mishra mentioned. “But it surely was sticker shock, and it simply doesn’t appear proper.”
Invoice of the Month is a crowdsourced investigation by KFF Well being Information and The Washington Publish’s Nicely+Being that dissects and explains medical payments. Since 2018, this collection has helped many sufferers and readers get their medical payments diminished, and it has been cited in statehouses, on the U.S. Capitol, and on the White Home. Do you could have a complicated or outrageous medical invoice you need to share? Inform us about it!
KFF Well being Information is a nationwide newsroom that produces in-depth journalism about well being points and is likely one of the core working packages at KFF—an unbiased supply of well being coverage analysis, polling, and journalism. Be taught extra about KFF.
USE OUR CONTENT
This story will be republished without cost (particulars).